RPS6 and Miyoshi myopathy: Combined, these associations suggest a bortezomib-sensitive MM state that is DEPTOR-low and RPS6-high, further characterized by high abundance of ribosomal, translational and mRNA splicing machinery (Fig. 6b–d).